Cargando…
Alectinib treatment response in lung adenocarcinoma patient with novel EML4‐ALK variant
Common gene fusion of the ALK gene is fusion of the ALK tyrosine kinase area and the 5’end of EML4. Seventeen EML4‐ALK fusion variants have been reported. Herein, we report a novel EML4‐ALK variant detected by next‐generation sequencing in a 36‐year‐old female lung adenocarcinoma patient who experie...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166076/ https://www.ncbi.nlm.nih.gov/pubmed/30133144 http://dx.doi.org/10.1111/1759-7714.12834 |